<DOC>
	<DOCNO>NCT02024100</DOCNO>
	<brief_summary>The study identify effectiveness Eprosartan pulse pressure hypertensive patient metabolic syndrome -Definition pulse pressure ( PP ) : Difference systolic diastolic blood pressure produce one heart beat .</brief_summary>
	<brief_title>Observational Study Investigate Effectiveness Eprosartan Pulse Pressure ( Teveten_MS )</brief_title>
	<detailed_description>Primary Objective -To ass change pulse pressure 12 week Secondary Objectives - To assess change pulse pressure 4 , 24 week - To assess change systolic blood pressure diastolic blood pressure visit - Percentage responder rate* visit time get normalized BP enrollment - Responder rate last visit - To assess IIEF-5 ( 5-item Version International Index Erectile Function ) score enrollment 24 week ( percentage patient ED accord IIEF-5 , Changes IIEF-5 domain ) - Percentage patient erectile dysfunction ( ED ) accord IIEF-5 change PP subgroup ( age 65 , body mass index ( BMI ) 23 , diabetes mellitus , dyslipidemia , benign prostate hypertrophy ) - Analysis correlation ED concomitant disease concomitant medication patient receive Eprosartan - Score change Framingham 10-year Coronary Heart Disease ( CHD ) risk 1st visit , 4th visit - Percentages Eprosartan monotherapy multiple antihypertensive therapy enrollment last visit - Reason treatment discontinuation ( Inadequate BP control , adverse event , others ) - Adverse event - Responder rate : SBP &lt; 140mmHg DBP &lt; 90mmHg ( SBP &lt; 140mmHg DBP &lt; 85mmHg patient diabetes mellitus )</detailed_description>
	<mesh_term>Eprosartan</mesh_term>
	<criteria>1 . 2080 year old patient 1st visit 2 . Patient determine prescribe Eprosartan hypertension ( patient least one follow condition ) ( 1 ) Newly diagnose hypertension ( 2 ) Inability tolerate hypertension ( example : adverse event ) ( 3 ) Lack response current antihypertensive medication 3 . Metabolic syndrome patient ( fulfill 3 component enrollment ) ( 1 ) Waist circumference ( &gt; 90 men , &gt; 80 woman ) ( 2 ) Triglycerides ( ≥150mg/dl ) ( 3 ) HDL cholesterol ( &lt; 40mg/dl men , &lt; 50mg/dl woman ) ( 4 ) SBP≥130mmHg DBP≥85mmHg antihypertensive medication ) ( 5 ) Fasting glucose level ( ≥100mg/dl ) antidiabetic medication MS diagnosis origin : Korean diabetes association 1 . Patients administer 3 3 antihypertensive drug 2 . Patients contraindicated Eprosartan product label</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>